In our previous study we could show that CFS/ME patients with elevated ß2 antibodies had higher IgG1-3 levels, more frequent T cell activation, and elevated ANA and TPO antibodies [4]. This evidence concerns the gene TPO and myalgic encephalomeyelitis/chronic fatigue syndrome.